<DOC>
	<DOCNO>NCT00395642</DOCNO>
	<brief_summary>This feasibility study investigate clinical benefit combine use BIOTRONIK Home Monitoring ( HM ) weight blood pressure ( BP ) external telemonitoring ( ETM ) follow-up treatment patient implanted Cardiac Resynchronization Therapy Implantable Cardioverter Defibrillator ( CRT-D ) . The feasibility study design plan define endpoint large randomize study . The study assess HM-parameter trend correlation daily weight blood pressure change . The patient compliance rate two different telemonitoring system ( HM &amp; ETM ) also evaluate .</brief_summary>
	<brief_title>TRIAGE-CRT Telemonitoring Patients With CHF Indication CRT-D</brief_title>
	<detailed_description>This single-arm , multi-center feasibility study explore clinical benefit combine use BIOTRONIK Home Monitoring ( HM ) weight blood pressure ( BP ) external telemonitoring ( ETM ) follow-up management heart failure patient implanted Cardiac Resynchronization Therapy Implantable Cardioverter Defibrillator ( CRT-D ) . The BIOTRONIK Home Monitoring system automatically remotely collect device base information daily basis , external telemonitoring system use determine 'weight ' 'blood pressure ' remotely patient 's home daily basis . This study evaluate retrospectively , Home Monitoring parameter correlate weight blood pressure change . The patient compliance rate two telemonitoring system also assess . Target enrollment 100 patient 15 U.S. site . Patients enrol within period 12 15 month . Based follow-up period 6 month per patient , study duration 18 21 month date first patient enrollment . All patient give write informed consent prior enrollment implant legally market BIOTRONIK Kronos LV-T , appropriate BIOTRONIK CRT-D , well legally market pace defibrillation lead . In addition , patient receive legally market external telemonitoring system determine weight blood pressure home .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Able provide write informed consent Implanted within past 45 day consider implant BIOTRONIK CRTD Age 18 year Able follow comply study related procedure Phone jack landline connection home connect BIOTRONIK HM ETM system Sufficient cognitive reading skill operate weight &amp; BP system Ambulatory Weight â‰¤ 400 lbs Participation another cardiovascular clinical study Life expectancy &lt; 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Congestive Heart Failure</keyword>
	<keyword>Cardiac Resynchronization Therapy</keyword>
	<keyword>Home Monitoring</keyword>
	<keyword>Telemonitoring</keyword>
	<keyword>Remote Monitoring</keyword>
</DOC>